Xuebao Wang

机构：Wenzhou Medical University · ORCID：0000-0002-5944-7603

发表论文 79 篇 · 总被引 960 次 · h-index 19

代表论文

• Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents (2024 · Frontiers in Chemistry · 被引 36)
• Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease (2024 · British Journal of Pharmacology · 被引 33)
• Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide (2021 · European Journal of Medicinal Chemistry · 被引 18)
• Discovery of 4-methoxy-N-(1-naphthyl)benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751 (2022 · Bioorganic Chemistry · 被引 10)
• The activation of spliced X-box binding protein 1 by isorhynchophylline therapy improves diabetic encephalopathy (2023 · Cell Biology and Toxicology · 被引 6)
• Novel biodegradable extinguishing gel: Preparation, fire-extinguishing performance and mechanism study (2025 · Colloids and Surfaces A Physicochemical and Engineering Aspects · 被引 4)